ANTI-DNA ANTIBODIES IN THE PRIMARY ANTIPHOSPHOLIPID SYNDROME (PAPS) (1993)
EHRENSTEIN, M. R., SWANA, M., KEELING, D., ASHERSON, R., HUGHES, G. R. V., ISENBERG, D. A.
Primary antiphospholipid syndrome (PAPS) is considered a distinct entity from SLE and patients with PAPS are generally regarded as being dsDNA antibody negative. Levels of IgG and IgM ss and ds DNA...
Haga, H J, D'Cruz, D, Asherson, R, Hughes, G R
A predominantly outpatient regimen of low dose intravenous cyclophosphamide was used to treat patients with serious progressive connective tissue diseases. Fifty five patients were treated with a...
Complement factor 2 deficiency: a clinical and serological family study.
D'Cruz, D, Taylor, J, Ahmed, T, Asherson, R, Khamashta, M, Hughes, G R
Inherited complement deficiencies are associated with a variety of connective tissue diseases. A family with inherited deficiency of complement factor 2 (C2) is described in which two family members...
Loizou, S, Singh, S, Wypkema, E, Asherson, R
Objectives: To investigate IgG, IgM, and IgA, antiphospholipid antibodies (aPL), against cardiolipin (aCL), ß2-glycoprotein I (anti-ß2GPI), and prothrombin (anti-PT), in black South African...
Long term outcome of catastrophic antiphospholipid syndrome survivors
Erkan, D, Asherson, R, Espinosa, G, Cervera, R, Font, J, Piette, J, ...
Background: Catastrophic antiphospholipid syndrome (APS) is defined as life threatening multiple organ thromboses developing simultaneously or over a short period. The survival rate of catastrophic...
Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies
Espinosa, G, Bucciarelli, S, Cervera, R, Lozano, M, Reverter, J, ...
Objective: To analyse the clinical and laboratory features of patients with thrombotic microangiopathic haemolytic anaemia (TMHA) associated with antiphospholipid antibodies (aPL).
Cervera, R, Asherson, R, Acevedo, M, Gomez-Puerta, J, Espinosa, G, ...
Objective: To describe and analyse the clinical characteristics of 100 patients with antiphospholipid syndrome (APS) associated with infections.
Asherson, R, Espinosa, G, Cervera, R, Gomez-Puerta, J, Musuruana, J, Bucciarelli, S, ...
Objective: To analyse the clinical and laboratory characteristics of catastrophic APS patients with DIC features.
Cervera, R, Font, J, Gomez-Puerta, J, Espinosa, G, Cucho, M, Bucciarelli, S, ...
Objective: To describe the characteristics of patients with catastrophic antiphospholipid syndrome (APS) included in the International Registry of patients with this condition (CAPS registry) and to...